ACST
$2.04
Acasti Pharma
$.29
16.57%
ACST
Earnings Whisper ®
N/A
3rd Quarter December 2019
Consensus:  ($0.07)
Revenue:  N/A
Wednesday
Feb 12
7:55 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ACST reports earnings?
Beat
Meet
Miss

Where is ACST's stock price going from here?
Up
Flat
Down
Stock chart of ACST
Analysts
Summary of analysts' recommendations for ACST
Score
Grade
Pivots
Resistance
$2.46
$2.26
$2.15

$1.95

Support
$1.84
$1.64
$1.53
Tweet
Growth
Peers
BioMarin PharmaceuticalRegeneron PharmaceuticalsInterCeptVertex PharmaceuticalsJohnson & JohnsonZoetisEndo International plcMylanUltragenyx PharmaceuticalBristol-Myers Squibb